Related Articles
Exemestane and Everolimus combination treatment of hormone receptor positive, HER2 negative metastatic breast cancer: A retrospective study of 9 cancer centers in the Campania Region (Southern Italy) focused on activity, efficacy and safety
Apatinib combined with chemotherapy in patients with previously treated advanced breast cancer: An observational study
Long‑term response to ipilimumab after nivolumab failure in a case of anorectal melanoma with an intermediate tumor mutation burden and negative for PD‑L1 expression
Maintenance immunotherapy in metastatic breast cancer
The significance of multi‑line chemotherapy for advanced gastric cancer: A retrospective analysis